| Description: |
Serum exosomal hsa_circ_0028861 is down-regulated in HBV-derived HCC versus chronic HBV/cirrhosis and serves as a diagnostic biomarker, including for small, early-stage, and AFP-negative HCC. Bioinformatics analyses suggest it may regulate target miRNAs and thereby affect tumor-related pathways (e.g., integrin, VEGF, PI3K/Akt, mTOR) potentially influencing HCC progression. |